US4717566A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Dosage system and method of using same
Assignee: Alza Corp
•
Filing: 1986-06-23
•
Granted: 1988-01-05
•
Expires: 2006-06-23
Abstract
Abstract A dosage form is disclosed for delivering a beneficial agent. The dosage form comprises a wall that surrounds and defines an internal space, a composition comprising a beneficial agent, means in the space for aiding in delivering the compositions from the dosage form and, at least one passageway in the wall for delivering the composition from the dosage form.
Inventors
- 👤 James B. Eckenhoff
- 👤 Richard Cortese
- 👤 Felix A. Landrau
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:58
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0068; A61K9/0002; A61K9/0004; Y; Y10; Y10S; Y10S424/00; Y10S424/10
Claims Analysis
Total Claims: 41
Claim 1
Independent Claim
146 words
A method for producing an antiparasitic effect in an animal suffering therewith, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a dosage unit amount of avermectin and at least one wax for forming a dispensable formulation in the space; (3) a composition comprising sodium carboxymethylcellulose and sodium chloride in the space; (4) a density member in the space, which density member maintains the dosage form in the animal environment over a prolonged period of time; and, (5) at least one exit means in the dosage form for delivering the avermectin; and, (b) administering the avermectin by composition (3) expanding in the space and exerting pressure against (2), whereby the avermectin is delivered through (5) to the animal for producing the antiparasitic effect.
Claim 2
Independent Claim
146 words
A method for producing an antiparasitic effect in an animal suffering therewith, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a dosage unit amount of avermectin and at least one wax for forming a dispensable formulation in the space; (3) a composition comprising sodium carboxymethylcellulose and sodium chloride in the space; (4) a density member in the space, which density member maintains the dosage form in the animal environment over a prolonged period of time; and, (5) at least one exit means in the dosage form for delivering the avermectin; and, (b) administering the avermectin by composition (3) expanding in the space and exerting pressure against (2), whereby the avermectin is delivered through (5) to the animal for producing the antiparasitic effect.
Claim 3
Dependent Claim
16 words
The method for producing the antiparasitic effect according to claim 1, wherein the method treats endoparasites.
Claim 4
Dependent Claim
16 words
The method for producing the antiparasitic effect according to claim 1, wherein the method treats ectoparasites.
Claim 5
Dependent Claim
17 words
The method for producing the antiparasitic effect according to claim 1, wherein the wall comprises tributyl citrate.
Claim 6
Dependent Claim
17 words
The method for producing the antiparasitic effect according to claim 1, wherein the wall comprises triethyl citrate.
Claim 7
Dependent Claim
20 words
The method for producing the antiparasitic effect according to claim 1, wherein the wall comprises tributyl citrate and triethyl citrate.
Claim 8
Dependent Claim
21 words
The method for producing the antiparasitic effect according to claim 1, wherein the composition comprising avermectin comprises two food grade waxes.
Claim 9
Dependent Claim
21 words
The method for producing the antiparasitic effect according to claim 1, wherein the avermectin produces an antiparasitic effect for managing ticks.
Claim 10
Dependent Claim
17 words
The method for producing the antiparasitic effect according to claim 1, wherein the avermectin is an ivermectin.
Claim 11
Independent Claim
150 words
A method for producing an antiparasitic effect in an animal suffering therewith, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a dosage unit amount of avermectin and at least one pharmaceutically acceptable wax for forming a dispensable formulation in the space; (3) a composition comprising a carboxyvinyl polymer and an osmotic agent in the space; (4) a density member in the space, which density member maintains the dosage form in the animal environment over a prolonged period of time; and, (5) at least one exit means in the dosage form for delivering the avermectin; and, (b) administering the avermectin by composition (3) expanding in the space and exerting pressure against (2), whereby the avermectin is delivered through (5) to the animal for producing the antiparasitic effect.
Claim 12
Independent Claim
150 words
A method for producing an antiparasitic effect in an animal suffering therewith, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a dosage unit amount of avermectin and at least one pharmaceutically acceptable wax for forming a dispensable formulation in the space; (3) a composition comprising a carboxyvinyl polymer and an osmotic agent in the space; (4) a density member in the space, which density member maintains the dosage form in the animal environment over a prolonged period of time; and, (5) at least one exit means in the dosage form for delivering the avermectin; and, (b) administering the avermectin by composition (3) expanding in the space and exerting pressure against (2), whereby the avermectin is delivered through (5) to the animal for producing the antiparasitic effect.
Claim 13
Dependent Claim
29 words
The method for producing an antiparasitic effect in an animal according to claim 10, wherein the carboxyvinyl polymer is sodium carboxyvinyl polymer and the osmotic agent is sodium chloride.
Claim 14
Independent Claim
129 words
A method for producing an antiparasitic effect in an animal suffering therewith, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) an antiparasitic formulation in the space comprising a beneficial amount of avermectin; (3) an expandable composition in the space comprising sodium polyacrlic acid and sodium chloride; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one exit means in the dosage form for releasing the avermectin; and, (b) administering the avermectin by the expandable composition expanding and urging the antiparasitic formulation through the exit means for producing the antiparasitic effect.
Claim 15
Independent Claim
129 words
A method for producing an antiparasitic effect in an animal suffering therewith, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) an antiparasitic formulation in the space comprising a beneficial amount of avermectin; (3) an expandable composition in the space comprising sodium polyacrlic acid and sodium chloride; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one exit means in the dosage form for releasing the avermectin; and, (b) administering the avermectin by the expandable composition expanding and urging the antiparasitic formulation through the exit means for producing the antiparasitic effect.
Claim 16
Dependent Claim
16 words
The method for producing the antiparasitic effect according to claim 12, wherein the method treats endoparasites.
Claim 17
Dependent Claim
16 words
The method for producing the antiparasitic effect according to claim 12, wherein the method treats ectoparasites.
Claim 18
Dependent Claim
17 words
The method for producing the antiparasitic effect according to claim 12, wherein the wall comprises tributyl citrate.
Claim 19
Dependent Claim
17 words
The method for producing the antiparasitic effect according to claim 12, wherein the wall comprises triethyl citrate.
Claim 20
Dependent Claim
20 words
The method for producing the antiparasitic effect according to claim 12, wherein the wall comprises tributyl citrate and triethyl citrate.
Claim 21
Dependent Claim
23 words
The method for producing the antiparasitic effect according to claim 12, wherein the composition comprising avermectin comprises two pharmaceutically acceptable food grade waxes.
Claim 22
Dependent Claim
21 words
The method for producing the antiparasitic effect according to claim 12, wherein the avermectin produces an antiparasitic effect for managing ticks.
Claim 23
Dependent Claim
17 words
The method for producing the antiparasitic effect according to claim 12, wherein the avermectin is an ivermectin.
Claim 24
Independent Claim
137 words
A method for administering selenium to an animal, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a beneficial amount of selenium and at least one wax carrier in the space; (3) a composition comprising sodium carboxymethylcellulose and sodium chloride in the space; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one dosage means in the dosage form for delivering the selenium; and, (b) administering the selenium to the animal by composition (3) expanding and exerting pressure against composition (2), whereby selenium is delivered through (5) to the animal over a prolonged period of time.
Claim 25
Independent Claim
137 words
A method for administering selenium to an animal, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a beneficial amount of selenium and at least one wax carrier in the space; (3) a composition comprising sodium carboxymethylcellulose and sodium chloride in the space; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one dosage means in the dosage form for delivering the selenium; and, (b) administering the selenium to the animal by composition (3) expanding and exerting pressure against composition (2), whereby selenium is delivered through (5) to the animal over a prolonged period of time.
Claim 26
Dependent Claim
18 words
The method for administering selenium to the animal according to claim 21, wherein the wall comprises tributyl citrate.
Claim 27
Dependent Claim
18 words
The method for administering selenium to the animal according to claim 21, wherein the wall comprises triethyl citrate.
Claim 28
Dependent Claim
18 words
The method for administering selenium to the animal according to claim 21, wherein the selenium is sodium selenite.
Claim 29
Dependent Claim
21 words
The method for administering selenium to the animal according to claim 21, wherein the composition comprising slenium comprises two different waxes.
Claim 30
Independent Claim
132 words
A method for administering selenium to an animal, which selenium method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a beneficial amount of selenium and at least one nontoxic wax carrier in the space; (3) an expandable composition in the space comprising sodium polyacrylic acid and sodium chloride; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one exit means in the dosage form for releasing the selenium; and, (b) administering the selenium by the expandable composition expanding and urging the selenium through the exit means for administering it to the animal.
Claim 31
Independent Claim
132 words
A method for administering selenium to an animal, which selenium method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose acetate butyrate and cellulose acetate, which wall defines an internal space; (2) a composition comprising a beneficial amount of selenium and at least one nontoxic wax carrier in the space; (3) an expandable composition in the space comprising sodium polyacrylic acid and sodium chloride; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one exit means in the dosage form for releasing the selenium; and, (b) administering the selenium by the expandable composition expanding and urging the selenium through the exit means for administering it to the animal.
Claim 32
Independent Claim
102 words
A method for establishing a blood level of avermectin in an animal in need of avermectin for the management of an infestation, which method comprises: introducing into the rumen of the animal a dosage form, which dosage form comprises a wall that surrounds and defines an internal lumen; a dosage amount of avermectin in the lumin; a pharmaceutically acceptable lipophilic carrier for avermectin in the lumin; and means for delivering said avermectin from the dosage form to the rumen of the animal at a controlled rate over a prolonged period of time for establishing the blood level of avermectin in said animal.
Claim 33
Independent Claim
102 words
A method for establishing a blood level of avermectin in an animal in need of avermectin for the management of an infestation, which method comprises: introducing into the rumen of the animal a dosage form, which dosage form comprises a wall that surrounds and defines an internal lumen; a dosage amount of avermectin in the lumin; a pharmaceutically acceptable lipophilic carrier for avermectin in the lumin; and means for delivering said avermectin from the dosage form to the rumen of the animal at a controlled rate over a prolonged period of time for establishing the blood level of avermectin in said animal.
Claim 34
Independent Claim
94 words
A method for the controlled release of trace elements in the digestive tract of an animal in need of a trace element, which method comprises; introducing into the digestive tract of the animal a dosage form, which dosage form comprise a wall that surrounds and defines a lumen; a dosage amount of a trace element in the lumen; a pharmaceutically acceptable lipophilic carrier for trace elements in the lumen; and means in the dosage form for delivering said trace element into the digestive tract at a controlled rate over a prolonged period of time.
Claim 35
Independent Claim
94 words
A method for the controlled release of trace elements in the digestive tract of an animal in need of a trace element, which method comprises; introducing into the digestive tract of the animal a dosage form, which dosage form comprise a wall that surrounds and defines a lumen; a dosage amount of a trace element in the lumen; a pharmaceutically acceptable lipophilic carrier for trace elements in the lumen; and means in the dosage form for delivering said trace element into the digestive tract at a controlled rate over a prolonged period of time.
Claim 36
Independent Claim
103 words
A method for producing a blood level of invermectin in a ruminant in need of invermectin for the management of an infestation, which method comprises: admitting into the ruminant a delivery device comprising a wall that surrounds and forms an internal compartment; a dosage amount of invermectin of the compartment; a pharmaceutically acceptable lipophilic carrier for invermectin in the compartment; means in the delivery device for delivering the ivermectin from the delivery device; and which delivery device administers the ivermectin to the ruminant at a controlled rate over a prolonged period of time for producing the blood level of ivermectin in the ruminant.
Claim 37
Independent Claim
103 words
A method for producing a blood level of invermectin in a ruminant in need of invermectin for the management of an infestation, which method comprises: admitting into the ruminant a delivery device comprising a wall that surrounds and forms an internal compartment; a dosage amount of invermectin of the compartment; a pharmaceutically acceptable lipophilic carrier for invermectin in the compartment; means in the delivery device for delivering the ivermectin from the delivery device; and which delivery device administers the ivermectin to the ruminant at a controlled rate over a prolonged period of time for producing the blood level of ivermectin in the ruminant.
Claim 38
Independent Claim
140 words
A method for producing a growth promotion effect in a warm-blooded animal by treating endo and ectoparasites in an animal afflicted with same, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose formulation, which wall defines an internal space; (2) a beneficial formulation in the space comprising an effective amount of avermectin; (3) an expandable composition in the space comprising a polyacrylic acid; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one exit means in the dosage form for releasing the avermectin; and, (b) administering the avermectin by the expandable composition expanding and urging the beneficial formulation through the exit means for treating the endo and ectoparasites thereby producing a growth promotion effect.
Claim 39
Independent Claim
140 words
A method for producing a growth promotion effect in a warm-blooded animal by treating endo and ectoparasites in an animal afflicted with same, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose formulation, which wall defines an internal space; (2) a beneficial formulation in the space comprising an effective amount of avermectin; (3) an expandable composition in the space comprising a polyacrylic acid; (4) a density member in the space, which density member maintains the dosage form in the animal over a prolonged period of time; and, (5) at least one exit means in the dosage form for releasing the avermectin; and, (b) administering the avermectin by the expandable composition expanding and urging the beneficial formulation through the exit means for treating the endo and ectoparasites thereby producing a growth promotion effect.
Claim 40
Independent Claim
150 words
A method for producing a growth promotion effect in a warm-blooded animal by treating endo and ectoparasites in an animal suffering with same, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose formulation, which wall defines an internal space; (2) a composition comprising a dosage unit amount of avermectin in at least one pharmaceutically acceptable carrier for forming a dispensable formulation in the space; (3) a composition comprising carboxymethylcellulose in the space; (4) a density member in the space, which density member maintains the dosage form in the animal environment over a prolonged period of time; and, (5) at least one exit means in the dosage form for delivering the avermectin; and, (b) administering the avermectin by the composition comprising carboxymethylcellulose expanding and urging the avermectin through the exit means for treating the endo and ectoparasites thereby producing a growth promotion effect.
Claim 41
Independent Claim
150 words
A method for producing a growth promotion effect in a warm-blooded animal by treating endo and ectoparasites in an animal suffering with same, which method comprises: (a) admitting into the animal a dosage form comprising: (1) a wall comprising cellulose formulation, which wall defines an internal space; (2) a composition comprising a dosage unit amount of avermectin in at least one pharmaceutically acceptable carrier for forming a dispensable formulation in the space; (3) a composition comprising carboxymethylcellulose in the space; (4) a density member in the space, which density member maintains the dosage form in the animal environment over a prolonged period of time; and, (5) at least one exit means in the dosage form for delivering the avermectin; and, (b) administering the avermectin by the composition comprising carboxymethylcellulose expanding and urging the avermectin through the exit means for treating the endo and ectoparasites thereby producing a growth promotion effect.
References Cited (Backward Citations)
US2340037A
Cited
FR1540258A
Cited
US3594469A
Cited
US3844285A
Cited
US3995631A
Cited
US3732865A
Cited
US3760804A
Cited
US4034756A
Cited
US3769805A
Cited
US3845770A
Cited
US3929132A
Cited
US3995632A
Cited
US4178361A
Cited
US4088864A
Cited
US4111202A
Cited
US4228149A
Cited
DE2729068A1
Cited
US4196187A
Cited
US4199569A
Cited
US4200098A
Cited
US4285987A
Cited
US4235236A
Cited
US4568547A
Cited
US4265874A
Cited
US4447254A
Cited
US4389397A
Cited
US4327725A
Cited
US4468220A
Cited
US4595583A
Cited
US4612186A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-01-04 | 1991-07-06 | 1992-01-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-01-04 | 1995-07-06 | 1996-01-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-01-04 | 1999-07-06 | 2000-01-05 | $7700.00 | Window Closed / Lapsed |